{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:33:16Z","timestamp":1792794796747,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"am","delay-in-days":302,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbi.2025.07.023","type":"journal-article","created":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T21:54:24Z","timestamp":1753653264000},"page":"890-897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The moderating role of lifetime social engagement on the relationship between C-reactive protein and negative symptoms among young adults at clinical high risk for psychosis"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4002-175X","authenticated-orcid":false,"given":"David R.","family":"Goldsmith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyue E.","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Addington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie E.","family":"Bearden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin S.","family":"Cadenhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyrone D.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo E.","family":"Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matcheri","family":"Keshavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Mathalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana O.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming T.","family":"Tsuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine F.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson S.","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2025.07.023_b0005","article-title":"Relations of Lifetime Perceived Stress and Basal Cortisol With Hippocampal Volume Among Healthy Adolescents and Those at Clinical High Risk for Psychosis: A Structural Equation Modeling Approach","author":"Aberizk","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0010","first-page":"171","article-title":"Life Event stress and Reduced Cortical Thickness in Youth at Clinical High Risk for Psychosis and healthy Control Subjects","volume":"7","author":"Aberizk","year":"2022","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.bbi.2025.07.023_b0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1192\/S0007125000292581","article-title":"Assessing depression in schizophrenia: the Calgary Depression Scale","author":"Addington","year":"1993","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.bbi.2025.07.023_b0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.schres.2012.09.012","article-title":"North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment","volume":"142","author":"Addington","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.07.023_b0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/NMD.0000000000000290","article-title":"North American Prodrome Longitudinal Study (NAPLS 2): the Prodromal Symptoms","volume":"203","author":"Addington","year":"2015","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.bbi.2025.07.023_b0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.schres.2013.12.014","article-title":"Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis","volume":"153","author":"Addington","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.07.023_b0035","article-title":"Cause or consequence? Understanding the role of cortisol in the increased inflammation observed in depression","volume":"24","author":"Amasi-Hartoonian","year":"2022","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"10.1016\/j.bbi.2025.07.023_b0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2023.2841","article-title":"Association of Childhood Area-Level Ethnic Density and Psychosis Risk among Ethnoracial Minoritized Individuals in the US","author":"Anglin","year":"2023","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.bbi.2025.07.023_b0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbi.2024.03.049","article-title":"Plasma complement and coagulation proteins as prognostic factors of negative symptoms: an analysis of the NAPLS 2 and 3 studies","volume":"119","author":"Byrne","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.07.023_b0050","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/schbul\/sbad184","article-title":"Proteomic Biomarkers for the Prediction of transition to Psychosis in individuals at Clinical High Risk: a Multi-cohort Model Development Study","volume":"50","author":"Byrne","year":"2024","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.07.023_b0055","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archgenpsychiatry.2011.2094","article-title":"Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration","volume":"69","author":"Capuron","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.schres.2024.06.054","article-title":"Neurocognition in adolescents and young adults at clinical high risk for psychosis: Predictive stability for social and role functioning","volume":"271","author":"Carri\u00f3n","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.07.023_b0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1192\/bjp.2023.21","article-title":"Psychosocial and behavioural interventions for the negative symptoms of schizophrenia: a systematic review of efficacy meta-analyses","volume":"223","author":"Cella","year":"2023","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"key":"10.1016\/j.bbi.2025.07.023_b0070","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1038\/tp.2015.91","article-title":"Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset","volume":"5","author":"Chan","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jphysparis.2017.05.002","article-title":"Altered circadian patterns of salivary cortisol in individuals with schizophrenia: a critical literature review","volume":"110","author":"Coulon","year":"2016","journal-title":"J. Physiol. Paris"},{"key":"10.1016\/j.bbi.2025.07.023_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.104649","article-title":"Stressor-Cortisol Concordance among individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort","volume":"115","author":"Cullen","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.07.023_b0085","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.euroneuro.2013.10.010","article-title":"Psychopharmacology of the negative symptoms: current status and prospects for progress","volume":"24","author":"Davis","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2025.07.023_b0090","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/schbul\/sbaa072","article-title":"Longitudinal Assessment and Functional Neuroimaging of Movement Variability Reveal Novel Insights into Motor Dysfunction in Clinical High Risk for Psychosis","volume":"46","author":"Dean","year":"2020","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.07.023_b0095","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.schres.2018.10.017","article-title":"Inflammatory biomarkers in psychosis and clinical high risk populations","volume":"206","author":"Delaney","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.07.023_b0100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/schbul\/sbq088","article-title":"Disorganization\/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis","volume":"38","author":"Demjaha","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.07.023_b0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/HRP.0000000000000273","article-title":"Negative Symptoms and Functioning in Youth at risk of Psychosis: a Systematic Review and Meta-analysis","volume":"28","author":"Devoe","year":"2020","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2307\/2136536","article-title":"Exemplification of a method for scaling life events: the Peri Life events Scale","volume":"19","author":"Dohrenwend","year":"1978","journal-title":"J. Health Soc. Behav."},{"key":"10.1016\/j.bbi.2025.07.023_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2022.105707","article-title":"Childhood immuno-metabolic markers and risk of depression and psychosis in adulthood: a prospective birth cohort study","volume":"139","author":"Donnelly","year":"2022","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.07.023_b0120","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/acps.13416","article-title":"Inflammation in first-episode psychosis: the contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis","volume":"146","author":"Dunleavy","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2025.07.023_b0125","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.biopsych.2010.06.010","article-title":"Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward","volume":"68","author":"Eisenberger","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0130","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.biopsych.2007.05.026","article-title":"Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression","volume":"62","author":"Felger","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0135","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/mp.2015.168","article-title":"Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression","volume":"21","author":"Felger","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1192\/bjp.2023.69","article-title":"A new era for the negative symptoms of schizophrenia","volume":"223","author":"Fernandez-Egea","year":"2023","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"key":"10.1016\/j.bbi.2025.07.023_b0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbi.2006.03.005","article-title":"Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses","volume":"21","author":"Frank","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.07.023_b0150","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biopsych.2022.11.003","article-title":"Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology","volume":"93","author":"Goldsmith","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0155","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bbi.2018.11.315","article-title":"Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis","volume":"76","author":"Goldsmith","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.07.023_b0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.schres.2018.02.048","article-title":"TNF-\u03b1 and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia","volume":"199","author":"Goldsmith","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.07.023_b0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-025-02114-2","article-title":"Inflammation is associated with avolition and reduced resting state functional connectivity in corticostriatal reward circuitry in patients with schizophrenia","author":"Goldsmith","year":"2025","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2025.07.023_b0170","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fpsyt.2020.00046","article-title":"Inflammation and negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits","volume":"11","author":"Goldsmith","year":"2020","journal-title":"Front. Psych."},{"key":"10.1016\/j.bbi.2025.07.023_b0175","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/17470919.2015.1070747","article-title":"The social buffering of the hypothalamic-pituitary-adrenocortical axis in humans: Developmental and experiential determinants","volume":"10","author":"Gunnar","year":"2015","journal-title":"Soc. Neurosci."},{"key":"10.1016\/j.bbi.2025.07.023_b0180","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.biopsych.2009.03.015","article-title":"Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity","volume":"66","author":"Harrison","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.schres.2013.04.022","article-title":"Assessment of everyday functioning in schizophrenia: implications for treatments aimed at negative symptoms","volume":"150","author":"Harvey","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.07.023_b0190","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/21507740.2015.1047054","article-title":"Social support can Buffer against stress and Shape Brain activity","volume":"6","author":"Hostinar","year":"2015","journal-title":"AJOB Neurosci."},{"key":"10.1016\/j.bbi.2025.07.023_b0195","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/s41380-023-02043-w","article-title":"The synaptic hypothesis of schizophrenia version III: a master mechanism","volume":"28","author":"Howes","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0200","article-title":"Cortisol and C-reactive protein (CRP) regulation in severe mental disorders","volume":"172","author":"Inova","year":"2024","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.07.023_b0205","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","article-title":"Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study","volume":"71","author":"Khandaker","year":"2014","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.bbi.2025.07.023_b0210","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jpsychires.2020.11.028","article-title":"Association between circulating levels of C-reactive protein and positive and negative symptoms of psychosis in adolescents in a general population birth cohort","volume":"143","author":"Khandaker","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2025.07.023_b0215","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/schbul\/sbj053","article-title":"The NIMH-MATRICS consensus statement on negative symptoms","volume":"32","author":"Kirkpatrick","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.07.023_b0220","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.schres.2017.05.032","article-title":"Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort","volume":"192","author":"Kline","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.07.023_b0225","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbi.2021.01.015","article-title":"Perceived stress is linked to heightened biomarkers of inflammation via diurnal cortisol in a national sample of adults","volume":"93","author":"Knight","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.07.023_b0230","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/schbul\/sbac055","article-title":"The Association between Neighborhood Poverty and Hippocampal volume among individuals at Clinical High-Risk for Psychosis: the Moderating Role of Social Engagement","volume":"48","author":"Ku","year":"2022","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.07.023_b0235","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.16484","article-title":"Aspects of Area Deprivation Index in Relation to Hippocampal volume among Children","volume":"7","author":"Ku","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.bbi.2025.07.023_b0240","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/s41386-023-01649-6","article-title":"Associations between childhood ethnoracial minority density, cortical thickness, and social engagement among minority youth at clinical high-risk for psychosis","volume":"48","author":"Ku","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2025.07.023_b0245","doi-asserted-by":"crossref","unstructured":"Ku, B.S., Ren, J., Compton, M.T., Druss, B.G., Guo, S., Walker, E.F., 2024b. The association between neighborhood-level social fragmentation and distressing psychotic-like experiences in early adolescence: the moderating role of close friends. , 1-9.","DOI":"10.1017\/S0033291724000278"},{"key":"10.1016\/j.bbi.2025.07.023_b0250","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbae141","article-title":"Associations between Genetic Risk, Physical Activities, and Distressing Psychotic-like Experiences","author":"Ku","year":"2024","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.07.023_b0255","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0920-9964(03)00214-7","article-title":"Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia","volume":"68","author":"Lencz","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.07.023_b0260","article-title":"Negative symptoms and neurocognition in drug-naive schizophrenia: moderating role of plasma neutrophil gelatinase-associated lipocalin (NGAL) and interferon-gamma (INF-gamma)","author":"Li","year":"2023","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2025.07.023_b0265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbi.2024.07.041","article-title":"White blood cell counts, ratios, and C-reactive protein among individuals with schizophrenia spectrum disorder and associations with long-term outcomes: a population-based study","volume":"122","author":"Llorca-Bofi","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.07.023_b0270","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/eip.13017","article-title":"Associations between childhood adversity, cognitive schemas and attenuated psychotic symptoms","volume":"15","author":"LoPilato","year":"2021","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0275","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1124\/pharmrev.120.000043","article-title":"Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications","volume":"73","author":"Lucido","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbi.2025.07.023_b0280","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/eip.12217","article-title":"Duration of active psychosis and first-episode psychosis negative symptoms","volume":"11","author":"Lyne","year":"2017","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0285","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/eip.12501","article-title":"Negative symptoms of psychosis: a life course approach and implications for prevention and treatment","volume":"12","author":"Lyne","year":"2018","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0290","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/cyto.1997.0290","article-title":"The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety","volume":"10","author":"Maes","year":"1998","journal-title":"Cytokine"},{"key":"10.1016\/j.bbi.2025.07.023_b0295","series-title":"The psychosis-risk syndrome: handbook for diagnosis and follow-up","author":"McGlashan","year":"2010"},{"key":"10.1016\/j.bbi.2025.07.023_b0300","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jan.13818","article-title":"The fear of needles: a systematic review and meta-analysis","volume":"75","author":"McLenon","year":"2019","journal-title":"J. Adv. Nurs."},{"key":"10.1016\/j.bbi.2025.07.023_b0305","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/npp.2016.211","article-title":"Towards an Immunophenotype of Schizophrenia: Progress, potential Mechanisms, and Future Directions","volume":"42","author":"Miller","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2025.07.023_b0310","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/oxfordjournals.schbul.a007040","article-title":"Prodromal Assessment with the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: Predictive Validity, Interrater Reliability, and Training to Reliability","volume":"29","author":"Miller","year":"2003","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.07.023_b0315","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1176\/appi.ajp.159.5.863","article-title":"Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity","volume":"159","author":"Miller","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0320","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jamapsychiatry.2020.2459","article-title":"Development of Proteomic Prediction Models for transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence","volume":"78","author":"Mongan","year":"2021","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.bbi.2025.07.023_b0325","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.psyneuen.2018.09.005","article-title":"Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis","volume":"99","author":"Nettis","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.07.023_b0330","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00213-013-3285-4","article-title":"Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5\/ chow feeding choice task","volume":"231","author":"Nunes","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2025.07.023_b0335","article-title":"Subgroups of Clinical High Risk for Psychosis based on Baseline Antipsychotic Exposure: Clinical and Outcome Comparisons across a 2-Year follow-up period","author":"Pelizza","year":"2024","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.07.023_b0340","doi-asserted-by":"crossref","unstructured":"Perkins, D.O., Jeffries, C.D., Addington, J., Bearden, C.E., Cadenhead, K.S., Cannon, T.D., Cornblatt, B.A., Mathalon, D.H., McGlashan, T.H., Seidman, L.J., Tsuang, M.T., Walker, E.F., Woods, S.W., Heinssen, R., 2015a. 41, 419-428.","DOI":"10.1093\/schbul\/sbu099"},{"key":"10.1016\/j.bbi.2025.07.023_b0345","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2021.02.008","article-title":"Childhood inflammatory markers and risks for psychosis and depression at age 24: Examination of temporality and specificity of association in a population-based prospective birth cohort","volume":"230","author":"Perry","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.07.023_b0350","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.psychres.2012.02.018","article-title":"Negative symptoms in individuals at clinical high risk of psychosis","volume":"196","author":"Piskulic","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2025.07.023_b0355","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neubiorev.2016.12.013","article-title":"The neural diathesis-stress model of schizophrenia revisited: an update on recent findings considering illness stage and neurobiological and methodological complexities","volume":"73","author":"Pruessner","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2025.07.023_b0360","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2012.01.015","article-title":"Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data","volume":"137","author":"Rabinowitz","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.07.023_b0365","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1176\/appi.ajp.160.9.1554","article-title":"When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders","volume":"160","author":"Raison","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0370","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.biopsych.2019.02.013","article-title":"Functional Connectivity of Corticostriatal Circuitry and Psychosis-like Experiences in the General Community","volume":"86","author":"Sabaroedin","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0375","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0166-4328(94)90108-2","article-title":"Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost\/benefit procedure","volume":"65","author":"Salamone","year":"1994","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2025.07.023_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2023.12.019","article-title":"Immune and oxidative stress biomarkers in pediatric psychosis and psychosis-risk: Meta-analyses and systematic review","volume":"117","author":"Taylor","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.07.023_b0385","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.tics.2019.03.003","article-title":"Can't or won't? Immunometabolic Constraints on Dopaminergic Drive","volume":"23","author":"Treadway","year":"2019","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.bbi.2025.07.023_b0390","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.schres.2014.09.017","article-title":"Stress exposure and sensitivity in the clinical high-risk syndrome: initial findings from the North American Prodrome Longitudinal Study (NAPLS)","volume":"160","author":"Trotman","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.07.023_b0395","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1017\/S0033291713000251","article-title":"Negative psychotic symptoms and impaired role functioning predict transition outcomes in the at-risk mental state: a latent class cluster analysis study","volume":"43","author":"Valmaggia","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2025.07.023_b0400","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1038\/npp.2014.141","article-title":"Lipopolysaccharide reduces incentive motivation while boosting preference for high reward in mice","volume":"39","author":"Vichaya","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2025.07.023_b0405","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1037\/a0018399","article-title":"Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth","volume":"119","author":"Walker","year":"2010","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.bbi.2025.07.023_b0410","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1037\/0033-295X.104.4.667","article-title":"Schizophrenia: a neural diathesis-stress model","volume":"104","author":"Walker","year":"1997","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.bbi.2025.07.023_b0415","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.biopsych.2013.02.016","article-title":"Cortisol levels and risk for psychosis: initial findings from the north American prodrome longitudinal study","volume":"74","author":"Walker","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.07.023_b0420","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.2147\/NDT.S418381","article-title":"Serum Levels of Tumor Necrosis Factor-alpha and Vascular Endothelial Growth factor in the Subtypes of Clinical High Risk individuals: a prospective Cohort Study","volume":"19","author":"Ye","year":"2023","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbi.2025.07.023_b0425","article-title":"Social network reductions are associated with negative symptoms in schizophrenia","author":"Zhang","year":"2024","journal-title":"Soc. Psychiatry Psychiatric Epidemiol."},{"key":"10.1016\/j.bbi.2025.07.023_b0430","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-022-02305-1","article-title":"Serum complement proteins rather than inflammatory factors is effective in predicting psychosis in individuals at clinical high risk","volume":"13","author":"Zhang","year":"2023","journal-title":"Trans. Psychiatry"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125002922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125002922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:56:44Z","timestamp":1759611404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125002922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":86,"alternative-id":["S0889159125002922"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.07.023","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The moderating role of lifetime social engagement on the relationship between C-reactive protein and negative symptoms among young adults at clinical high risk for psychosis","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}